Breaking News

Parexel Launches COVID-19 Risk Mitigation Offering

Four-step methodology aims ensure manufacturers can safely continue manufacturing operations through the COVID-19 pandemic

By: Contract Pharma

Contract Pharma Staff

Parexel has launched a COVID-19 Risk Mitigation offering leveraging its experience with global viral outbreaks as well as cGMP inspection and CMC review processes to help manufacturers safely continue operations through the COVID-19 pandemic. Parexel’s regulatory experts will partner with life sciences companies to help ensure business continuity by analyzing manufacturing operations to reduce the risk of viral contamination. The four-step methodology, including risk assessment, development o...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters